Re-emergence of human T-lymphotropic viruses in West Africa.

Nneoma Confidence JeanStephanie Anyanwu, Elijah Ekah Ella, Aghogho Ohwofasa, Maryam Aminu
Author Information
  1. Nneoma Confidence JeanStephanie Anyanwu: Ahmadu Bello University, Faculty of Life Sciences, Department of Microbiology, Zaria, Nigeria; COMSATS University, Department of Biosciences, Islamabad, Pakistan. Electronic address: anyanwunneomaconfidence@gmail.com.
  2. Elijah Ekah Ella: Ahmadu Bello University, Faculty of Life Sciences, Department of Microbiology, Zaria, Nigeria.
  3. Aghogho Ohwofasa: COMSATS University, Department of Biosciences, Islamabad, Pakistan.
  4. Maryam Aminu: Ahmadu Bello University, Faculty of Life Sciences, Department of Microbiology, Zaria, Nigeria.

Abstract

Human T-lymphotropic viruses (HTLV) are Deltaretroviruses that infect millions of individuals worldwide via the same transmission routes as HIV. With the aim of exposing the possible re-emergence of HTLV in West Africa since discovery, a systematic review was carried out, focusing on the distribution of the virus types and significance of frequent indeterminate reports, while highlighting the need for mandatory routine blood screening. Capturing relevant data from discovery till date, sources searched were Google Scholar, CrossRef, NCBI (PubMed), MEDLINE, Research Gate, Mendeley, abstracts of Conferences and Proceedings, organization websites and reference lists of selected papers. A total of 2626 references were initially retrieved using search terms: Worldwide prevalence of HTLV, HTLV in Africa, HTLV in West Africa, HTLV subtypes, HTLV 3 and 4 in Africa, HTLV of African origin, HTLV seroindeterminate results, Spread of HTLV. These references were rigorously trimmed down to 76. Although evidence shows that HTLV is still endemic in the region, West Africa lacks recent epidemiological prevalence data. Thorough investigations are needed to ascertain the true cause of indeterminate Western Blot results. It is imperative that routine screening for HTLVs be mandated in West African health care facilities.

Keywords

References

  1. J Infect Dis. 1989 Sep;160(3):363-70 [PMID: 2547879]
  2. Int J Cancer. 1984 Aug 15;34(2):215-9 [PMID: 6088402]
  3. Transfus Clin Biol. 2014 Jun;21(3):139-42 [PMID: 24948205]
  4. J Infect Dis. 2003 Dec 1;188(11):1648-51 [PMID: 14639534]
  5. Trop Med Int Health. 1996 Apr;1(2):205-9 [PMID: 8665385]
  6. Bull Soc Pathol Exot. 2000 Feb;93(1):3-5 [PMID: 10774482]
  7. AIDS Res Hum Retroviruses. 1994 May;10(5):617-20 [PMID: 7917523]
  8. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):187-92 [PMID: 8680891]
  9. J Gen Virol. 1994 Dec;75 ( Pt 12):3655-66 [PMID: 7996161]
  10. Med Trop (Mars). 2005 Nov;65(6):525-8 [PMID: 16555510]
  11. J Virol. 1998 May;72(5):4327-40 [PMID: 9557723]
  12. Virol J. 2017 Jan 30;14(1):14 [PMID: 28137274]
  13. PLoS Negl Trop Dis. 2012;6(6):e1690 [PMID: 22720106]
  14. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):607-10 [PMID: 18645510]
  15. J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):418-20 [PMID: 8133454]
  16. J Acquir Immune Defic Syndr (1988). 1989;2(5):481-5 [PMID: 2552069]
  17. J Clin Microbiol. 2006 Apr;44(4):1550-4 [PMID: 16597891]
  18. J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):269-73 [PMID: 18398969]
  19. Med Microbiol Immunol. 1984;173(3):167-70 [PMID: 6095000]
  20. Vox Sang. 1994;67(1):79-80 [PMID: 7975460]
  21. Br J Ophthalmol. 1996 Nov;80(11):956-61 [PMID: 8976721]
  22. J Med Virol. 1996 Jan;48(1):22-32 [PMID: 8825706]
  23. Vox Sang. 2009 Feb;96(2):104-10 [PMID: 19076337]
  24. Front Microbiol. 2012 Nov 15;3:388 [PMID: 23162541]
  25. Leukemia. 1998 Apr;12(4):578-85 [PMID: 9557617]
  26. AIDS Res Hum Retroviruses. 1994 Dec;10(12):1747-50 [PMID: 7888235]
  27. J Med Microbiol. 2006 Jun;55(Pt 6):765-770 [PMID: 16687597]
  28. J Biol Chem. 2002 Feb 22;277(8):5699-702 [PMID: 11741967]
  29. J Infect Dis. 2014 Feb 15;209(4):486-7 [PMID: 24154735]
  30. Viruses. 2016 Sep 05;8(9): [PMID: 27608036]
  31. Jpn J Infect Dis. 2003 Apr;56(2):57-9 [PMID: 12824686]
  32. Proc Natl Acad Sci U S A. 2005 May 31;102(22):7994-9 [PMID: 15911757]
  33. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 1;15(4):320-2 [PMID: 9292595]
  34. Med Trop (Mars). 1996;56(1):100-1 [PMID: 8767804]
  35. J Med Virol. 2006 May;78(5):683-92 [PMID: 16555290]
  36. J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):157-63 [PMID: 11103046]
  37. J Gen Virol. 1996 Feb;77 ( Pt 2 ):359-68 [PMID: 8627240]
  38. AIDS Res Hum Retroviruses. 1993 Aug;9(8):709-13 [PMID: 8217340]
  39. J Blood Med. 2015 Jan 19;6:31-6 [PMID: 25632240]
  40. AIDS Rev. 2004 Jul-Sep;6(3):144-54 [PMID: 15595431]
  41. AIDS. 1992 May;6(5):510-1 [PMID: 1616658]
  42. Mem Inst Oswaldo Cruz. 2016 Sep;111(9):594-6 [PMID: 27653363]
  43. Vox Sang. 2001 Apr;80(3):142-7 [PMID: 11840974]
  44. AIDS Res Hum Retroviruses. 1991 May;7(5):447-51 [PMID: 1873079]
  45. J Clin Epidemiol. 2002 Feb;55(2):192-6 [PMID: 11809358]
  46. Int J Epidemiol. 1995 Feb;24(1):198-203 [PMID: 7797344]
  47. Transfus Clin Biol. 2016 Feb;23(1):13-9 [PMID: 26778839]
  48. Nature. 1992 Sep 17;359(6392):201 [PMID: 1528262]
  49. J Immunoassay Immunochem. 2016;37(1):29-42 [PMID: 25879258]
  50. Rev Inst Med Trop Sao Paulo. 2015 Jan-Feb;57(1):1-13 [PMID: 25651320]
  51. Afr Health Sci. 2007 Sep;7(3):129-32 [PMID: 18052864]
  52. Int J Cancer. 1988 Jul 15;42(1):7-12 [PMID: 2899060]
  53. Oncogene. 2005 Sep 5;24(39):6058-68 [PMID: 16155612]
  54. Retrovirology. 2016 Aug 12;13(1):56 [PMID: 27519553]
  55. Am J Trop Med Hyg. 1994 Apr;50(4):479-86 [PMID: 8166356]
  56. J Acquir Immune Defic Syndr (1988). 1993 Dec;6(12):1373-4 [PMID: 8254478]
  57. Emerg Infect Dis. 2009 Jul;15(7):1116-8 [PMID: 19624934]
  58. J Clin Microbiol. 2008 Nov;46(11):3607-14 [PMID: 18845819]
  59. Pan Afr Med J. 2014 Apr 21;17:301 [PMID: 25328597]
  60. Int J Womens Health. 2014 Sep 18;6:849-55 [PMID: 25258559]
  61. AIDS Res Hum Retroviruses. 1993 Jun;9(6):505-11 [PMID: 8347395]
  62. Int J Hematol. 2002 Aug;76 Suppl 2:240-5 [PMID: 12430931]
  63. J Trop Pediatr. 1999 Apr;45(2):66-70 [PMID: 10341498]
  64. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):315-8 [PMID: 7859147]
  65. Bull Acad Natl Med. 1988 May;172(5):717-22 [PMID: 3056585]
  66. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):430-2 [PMID: 9833756]
  67. Cent Afr J Med. 1998 May;44(5):130-4 [PMID: 9810411]
  68. Retrovirology. 2010 Jun 04;7:50 [PMID: 20525366]
  69. AIDS. 1991 Jan;5(1):69-75 [PMID: 2059363]
  70. Trop Med Int Health. 2016 Mar;21(3):312-24 [PMID: 26700941]

MeSH Term

Africa, Western
Deltaretrovirus
Deltaretrovirus Infections
Female
Humans
Male
Prevalence
Risk Factors
Seroepidemiologic Studies

Word Cloud

Created with Highcharts 10.0.0HTLVAfricaWestT-lymphotropicvirusesindividualsdiscoverydistributionindeterminateroutinescreeningdatareferencesWorldwideprevalenceAfricanresultsHumanDeltaretrovirusesinfectmillionsworldwideviatransmissionroutesHIVaimexposingpossiblere-emergencesincesystematicreviewcarriedfocusingvirustypessignificancefrequentreportshighlightingneedmandatorybloodCapturingrelevanttilldatesourcessearchedGoogleScholarCrossRefNCBIPubMedMEDLINEResearchGateMendeleyabstractsConferencesProceedingsorganizationwebsitesreferencelistsselectedpaperstotal2626initiallyretrievedusingsearchterms:subtypes34originseroindeterminateSpreadrigorouslytrimmed76AlthoughevidenceshowsstillendemicregionlacksrecentepidemiologicalThoroughinvestigationsneededascertaintruecauseWesternBlotimperativeHTLVsmandatedhealthcarefacilitiesRe-emergencehumanATLLBloodtransfusionEpidemiologyHAM/TSPSeroindeterminate

Similar Articles

Cited By